Medical device
The listing of a minority of the unit, which makes X-ray and MRI machines, is set to take place in the first half of 2018.
The funds raised will be used to further commercialize reSET and its pipeline and platform.
The company announced the study in a blog post on its website.
This is definitely a list few, if any, companies want to be on.
Apple’s research into non-invasive glucose monitoring remains ongoing.
Both companies are noted for growth through acquisition, and 2017 has been a very big year for LabCorp.
The group has bought 11 businesses in the past seven years.
It was a pretty good year for the stock market, but how about for biotech stocks?
The military reviewed bids from 31 suitors and is good to Dec. 20, 2022.
PRESS RELEASES